DASH After TBI Study: Decreasing Adrenergic or Sympathetic Hyperactivity After Traumatic Brain Injury

PHASE2CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

January 31, 2015

Study Completion Date

December 31, 2016

Conditions
Brain InjuriesCraniocerebral TraumaTrauma, Nervous SystemTraumatic Brain Injury
Interventions
DRUG

IV Propranolol and Per Tube Clonidine

1 mg IV q6h Propranolol and 0.1 mg Per Tube Clonidine, both for 7 days

DRUG

Placebo

Placebo IV q6h and Per Tube q12, both for 7 days

Trial Locations (1)

37212

Vanderbilt University Medical Center, Nashville

All Listed Sponsors
collaborator

Vanderbilt University Medical Center

OTHER

collaborator

Eastern Association for the Surgery of Trauma (EAST)

UNKNOWN

lead

Vanderbilt University

OTHER

NCT01322048 - DASH After TBI Study: Decreasing Adrenergic or Sympathetic Hyperactivity After Traumatic Brain Injury | Biotech Hunter | Biotech Hunter